MYGN
Myriad Genetics Inc
NASDAQ: MYGN · HEALTHCARE · DIAGNOSTICS & RESEARCH
$4.11
-18.29% today
Updated 2026-05-06
Market cap
$475.05M
P/E ratio
—
P/S ratio
0.85x
EPS (TTM)
$-4.31
Dividend yield
—
52W range
$4 – $9
Volume
1.9M
Myriad Genetics Inc (MYGN) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $158.96M | $276.60M | $372.07M | $499.34M | $466.42M | $593.85M | $610.83M | $690.63M | $803.82M | $823.81M | $766.20M | $880.50M | $1.22B | $1.17B | $1.56B | $1.42B | $1.32B | $1.20B | $1.15B | $1.03B |
| Cash & equivalents | $49.51M | $98.57M | $143.43M | $237.73M | $63.51M | $92.84M | $52.68M | $86.35M | $104.07M | $64.82M | $64.10M | $68.50M | $102.40M | $110.90M | $93.20M | $117.00M | $258.40M | $56.90M | $132.10M | $102.40M |
| Current assets | $135.56M | $252.29M | $343.26M | $377.30M | $366.15M | $540.57M | $479.33M | $530.61M | $634.73M | $400.10M | $283.60M | $314.50M | $317.10M | $326.40M | $348.60M | $389.40M | $484.80M | $274.60M | $313.60M | $298.00M |
| Total liabilities | $23.29M | $26.82M | $31.70M | $73.69M | $32.20M | $36.27M | $44.03M | $54.98M | $75.23M | $104.82M | $104.10M | $132.40M | $446.60M | $209.20M | $473.80M | $537.80M | $352.90M | $312.90M | $363.30M | $326.50M |
| Current liabilities | $23.29M | $26.82M | $31.70M | $73.69M | $32.20M | $36.27M | $44.03M | $44.97M | $64.51M | $80.58M | $68.70M | $72.30M | $217.50M | $102.20M | $117.80M | $145.90M | $204.30M | $137.20M | $155.90M | $164.10M |
| Long-term debt | — | — | — | — | — | — | — | — | — | — | — | — | — | — | $224.40M | — | — | — | $38.50M | $39.60M |
| Shareholder equity | $135.67M | $249.78M | $340.36M | $425.65M | $434.22M | $557.58M | $566.79M | $635.66M | $728.59M | $719.00M | $662.10M | $748.10M | $778.20M | $964.90M | $1.09B | $881.00M | $967.80M | $885.80M | $783.20M | $701.10M |
| Retained earnings | $-179.25M | $-217.44M | $-252.40M | $-204.56M | $-119.94M | $-10.46M | $-38.63M | $-12.68M | $30.87M | $2.00M | $-77.00M | $-73.20M | $-68.40M | $52.80M | $25.60M | $-227.00M | $-254.20M | $-366.20M | $-629.50M | $-756.80M |
| Accounts receivable | $18.38M | $22.22M | $32.45M | $45.43M | $45.30M | $48.13M | $50.27M | $63.10M | $96.98M | $98.68M | $87.70M | $95.00M | $111.30M | $102.10M | $138.60M | $89.50M | $91.30M | $101.60M | $114.30M | $121.20M |
| Inventory | — | — | — | — | — | $-399.17M | $5.67M | $11.57M | $5.01M | $23.92M | $25.10M | $38.30M | $42.20M | $34.30M | $31.40M | $27.10M | $15.30M | $20.10M | $22.00M | $27.50M |
| Goodwill | — | — | — | — | — | — | $56.05M | $56.85M | $56.85M | $169.18M | $177.20M | $195.30M | $316.10M | $318.60M | $417.20M | $329.20M | $239.20M | $286.80M | $287.40M | $286.30M |